IL6 and neoplasm: The outcomes of their investigation revealed promising effects, including the mitigation of tumor-induced elevation of muscle IL-6 transcript levels and downregulation of Bcl-2/adenovirus E1B 19-kDa-interacting protein (BNIP3), a marker associated with mitophagy [26].